Immunocore Holdings Ltd
IMCR
$31.29-0.79%
End of day · as of Sep 24, 2026, 8:30 PM ET
Mkt cap
$1.45B
EV/Sales
2.46
P/E ratio
N/A
FY2025 Revenue
$400.02M
EPS (TTM)
$-0.37
Gross Margin (FY2025)
98.73%
Profit Margin (FY2025)
-8.88%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Latest reported IMCR revenue for 2025-12-31 was $400.0M. Net income was -$35.5M. Revenue was up 29.0% from 2024-12-31 to 2025-12-31. IMCR currently screens at market cap $1.45B.
Use this IMCR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IMCR income, balance, and cash tables.
Immunocore Holdings Ltd (IMCR) is a biotechnology company in the Healthcare sector.
Latest cached Immunocore Holdings Ltd (IMCR) revenue for Dec 31, 2025 was $400.0M. Net income was -$35.5M. Statements: https://lician.com/financials/imcr
Immunocore Holdings Ltd (IMCR) market capitalization is $1.45B on the latest cached snapshot.
Immunocore Holdings Ltd (IMCR) cached previous close $31.54; day range $30.71 – $33.86; volume 640,452. Session quote: https://lician.com/quote/imcr
Immunocore Holdings Ltd (IMCR) latest cached earnings event is "IMCR earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IMCR filing is 8-K · Sep 14, 2026. Filings: https://lician.com/sec/imcr